Rank 96 • Consumer & Prevention
Signos
Pairs continuous glucose monitoring hardware with AI-driven software to guide personalized nutrition and weight loss.
Visit website- Signal Score
- 79.3
- Total raised
- $37M
- Stage
- Series B
- Founded
- 2018
- Headquarters
- San Mateo, USA
- Region
- North America
Their signal
Signos addresses metabolic wellness and weight management by linking glucose data with real-time dietary suggestions. This positioning within the booming wellness and medical weight-loss space drives its strong consumer pull.
Signal Score 79.3editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Consumer & Prevention
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.